Sinsin Pharmaceutical Co. Ltd (002800) — Long-term Investment Intensity
Sinsin Pharmaceutical Co. Ltd (002800) has a Long-term Investment Intensity of 0.1% as of September 2019. Long-term investments of ₩108.95 Million represent 0.1% of total assets of ₩129.56 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See 002800 net asset value for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Sinsin Pharmaceutical Co. Ltd Long-term Investment Intensity (2016–2018)
This chart shows how Sinsin Pharmaceutical Co. Ltd's Long-term Investment Intensity has evolved across 3 annual periods from 2016 to 2018. As of September 2019, the intensity stands at 0.1%, reflecting long-term investments of ₩108.95 Million against total assets of ₩129.56 Billion KRW. Also explore Sinsin Pharmaceutical Co. Ltd total assets for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Sinsin Pharmaceutical Co. Ltd (2016–2018)
The table below presents the year-by-year Long-term Investment Intensity for Sinsin Pharmaceutical Co. Ltd from 2016 to 2018, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Sinsin Pharmaceutical Co. Ltd (002800) total market value.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 0.1% | ₩106.35 Million | ₩107.92 Billion | ▼ 0.0 pp |
| 2017 | 0.1% | ₩100.28 Million | ₩78.85 Billion | ▼ 0.0 pp |
| 2016 | 0.1% | ₩96.76 Million | ₩68.81 Billion | — |